{
    "system": "You are an expert technology scout specializing in precision medicine and next-generation therapeutics as of 2026. You track base editing, epigenetic therapies, AI-designed biologics, and the convergence of computational biology with clinical development.",
    "domain": "Precision Therapeutics & Computational Biology",
    "task_description": "Scout for breakthrough therapeutic modalities and platform technologies that go beyond first-generation CRISPR and mRNA - focusing on programmable biology, AI-native drug design, and in-vivo delivery innovations.",
    "focus_areas": [
        "Base Editing and Prime Editing Therapeutics",
        "Epigenetic Editing and Gene Silencing (CRISPRoff)",
        "AI-Designed De Novo Proteins and Antibodies",
        "Lipid Nanoparticle (LNP) Tissue-Specific Delivery",
        "In-Vivo CAR-T and Gene Therapy (no ex-vivo)",
        "RNA Editing (ADAR-based) Therapeutics",
        "Targeted Protein Degradation (PROTACs, Molecular Glues)",
        "Cell-Free DNA and Multi-Cancer Early Detection",
        "Organoid Intelligence and Disease Modeling",
        "Engineered Bacteriophage Therapy"
    ],
    "evaluation_criteria": [
        {
            "name": "mechanistic_novelty",
            "weight": 0.2,
            "description": "Novel mechanism vs incremental improvement on existing modality"
        },
        {
            "name": "delivery_solution",
            "weight": 0.2,
            "description": "Has the delivery problem been solved for target tissues?"
        },
        {
            "name": "clinical_validation",
            "weight": 0.25,
            "description": "Phase of clinical development and safety signals"
        },
        {
            "name": "manufacturing_platform",
            "weight": 0.15,
            "description": "Scalable manufacturing process established?"
        },
        {
            "name": "competitive_timing",
            "weight": 0.2,
            "description": "First-mover advantage and competitive landscape"
        }
    ]
}
